naloxone hci

Generic: naloxone hci

Labeler: hf acquisition co. llc, dba health first
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naloxone hci
Generic Name naloxone hci
Labeler hf acquisition co. llc, dba health first
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

naloxone hydrochloride .4 mg/mL

Manufacturer
HF Acquisition Co. LLC, DBA Health First

Identifiers & Regulatory

Product NDC 51662-1242
Product ID 51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA070256
Listing Expiration 2026-12-31
Marketing Start 2018-08-18

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621242
Hyphenated Format 51662-1242

Supplemental Identifiers

RxCUI
1659929
UNII
F850569PQR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naloxone hci (source: ndc)
Generic Name naloxone hci (source: ndc)
Application Number ANDA070256 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • .4 mg/mL
source: ndc
Packaging
  • 1 mL in 1 VIAL (51662-1242-1)
  • 50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2)
source: ndc

Packages (2)

51662-1242-1 1 mL in 1 VIAL (51662-1242-1) 51662-1242-3 50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2)

Ingredients (1)

naloxone hydrochloride (.4 mg/mL)

Linked Drug Pages (1)

NALOXONE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "0ff862db-44cb-aac2-e063-6394a90a8a5d", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["73c1bad3-6ac3-8682-e053-2a91aa0a176a"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA Health First"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1242-1)", "package_ndc": "51662-1242-1", "marketing_start_date": "20180818"}, {"sample": false, "description": "50 POUCH in 1 CASE (51662-1242-3)  / 1 mL in 1 POUCH (51662-1242-2)", "package_ndc": "51662-1242-3", "marketing_start_date": "20200615"}], "brand_name": "NALOXONE HCI", "product_id": "51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1242", "generic_name": "NALOXONE HCI", "labeler_name": "HF Acquisition Co. LLC, DBA Health First", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HCI", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070256", "marketing_category": "ANDA", "marketing_start_date": "20180818", "listing_expiration_date": "20261231"}